PureHoney Technologies Announces Rebranding to Momentum Biotechnologies to Better Reflect Its Mission

Momentum Biotechnologies, formerly known as PureHoney Technologies, is a leading CRO focused on providing mass spectrometry-based native detection technologies for lead discovery and the quantification of difficult targets to biopharmaceutical clients globally. The new name better reflects the company’s commitment to solving difficult problems and rapidly returning high-quality data to its clients while maintaining the momentum of their projects.

“We’re excited to introduce our new name, which captures our mission of maintaining the momentum of our clients’ discovery research,” said Can Ozbal, Founder and CEO of Momentum Biotechnologies. “Our commitment to maintaining high-touch, collaborative relationships with our clients remains the same, and we will continue to offer our current services with the same rapid turnaround time you have come to expect from us.”

Momentum Biotechnologies is the leading provider of solution phase Affinity Selection Mass Spectrometry (ASMS) for RNA and protein targets. The company helps clients identify leads for “undruggable targets” and novel mechanisms of action such as protein degradation/molecular glues, protein-protein interaction disruption, and covalent modification. The company also offers functional screens on RapidFire-MS, potency assays, biomarker quantification, and ICP-MS analysis.

All client projects will have the same touchpoints and rapid data delivery, all phone numbers will remain the same, and all email addresses will be redirected to the company’s new addresses at momentum.bio.